S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
66,000% upside on tiny biotech? (Ad)
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
66,000% upside on tiny biotech? (Ad)
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
66,000% upside on tiny biotech? (Ad)
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
The single greatest medical breakthrough of all time? (Ad)
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
66,000% upside on tiny biotech? (Ad)
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
66,000% upside on tiny biotech? (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
NASDAQ:XCUR

Exicure (XCUR) Stock Forecast, Price & News

$0.75
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.72
$0.81
50-Day Range
$0.74
$1.30
52-Week Range
$0.63
$1.96
Volume
6,114 shs
Average Volume
16,627 shs
Market Capitalization
$6.50 million
P/E Ratio
0.45
Dividend Yield
N/A
Price Target
N/A

XCUR stock logo

About Exicure (NASDAQ:XCUR) Stock

Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

XCUR Price History

XCUR Stock News Headlines

Exicure (NASDAQ:XCUR) Trading Down 12.1%
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Exicure (XCUR) Earnings Dates & Reports
Exicure Lays Off Two-Third Employees, Ceases R&D Activities
See More Headlines
Receive XCUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter.

XCUR Company Calendar

Last Earnings
8/11/2023
Today
9/24/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:XCUR
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-2,580,000.00
Pretax Margin
13.76%

Debt

Sales & Book Value

Annual Sales
$28.83 million
Book Value
$3.00 per share

Miscellaneous

Free Float
8,311,000
Market Cap
$6.50 million
Optionable
Not Optionable
Beta
1.31
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Paul Kang (Age 61)
    CEO & Director
  • Ms. Jiyoung Hwang (Age 46)
    CFO & Director
  • Mr. Joshua Miller (Age 47)
    Chief Accounting Officer
  • Mr. Bart Anderson
    Sr. Director of R&D













XCUR Stock - Frequently Asked Questions

How have XCUR shares performed in 2023?

Exicure's stock was trading at $1.15 at the beginning of the year. Since then, XCUR stock has decreased by 34.7% and is now trading at $0.7510.
View the best growth stocks for 2023 here
.

When is Exicure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our XCUR earnings forecast
.

How were Exicure's earnings last quarter?

Exicure, Inc. (NASDAQ:XCUR) announced its quarterly earnings results on Friday, August, 11th. The company reported ($0.68) earnings per share for the quarter. Exicure had a positive trailing twelve-month return on equity of 34.49% and a negative net margin of 8.96%.

When did Exicure's stock split?

Exicure shares reverse split on the morning of Thursday, June 30th 2022. The 1-30 reverse split was announced on Thursday, June 30th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What is Exicure's stock symbol?

Exicure trades on the NASDAQ under the ticker symbol "XCUR."

Who are Exicure's major shareholders?

Exicure's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Carlson Capital L P (1.45%) and Citadel Advisors LLC (0.58%). Insiders that own company stock include Bali Muralidhar, Cbi Usa, Inc, Elias D Papadimas and Gates Frontier, Llc.
View institutional ownership trends
.

How do I buy shares of Exicure?

Shares of XCUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exicure's stock price today?

One share of XCUR stock can currently be purchased for approximately $0.75.

How much money does Exicure make?

Exicure (NASDAQ:XCUR) has a market capitalization of $6.50 million and generates $28.83 million in revenue each year. The company earns $-2,580,000.00 in net income (profit) each year or $1.68 on an earnings per share basis.

How can I contact Exicure?

Exicure's mailing address is 2430 N. Halsted St., Chicago IL, 60614. The official website for the company is www.exicuretx.com. The company can be reached via phone at (847) 673-1700 or via email at ir@exicuretx.com.

This page (NASDAQ:XCUR) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -